Atlas Trials

Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients

Clinical trial NCT05148949 · UNKNOWN

Trial details

NCT number
NCT05148949
Sponsor
Jiangsu Province Centers for Disease Control and Prevention
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19Pulmonary Tuberculosis
Start date
2021-12-22
Primary completion
2022-12-10
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.